Clinical trials
Hyperlipidemias trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National University of Singapore | 4 |
| Kastle Therapeutics, LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Alexandra Hospital | 1 |
| JeyaKumar Henry | 1 |
| National University Hospital, Singapore | 1 |
| Pfizer | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 13 |
| Dyslipidemias | 4 |
| Hypercholesterolemia | 4 |
| Hypertension | 4 |
| Chronic Disease | 2 |
| Congenital Abnormalities | 2 |
| Genetic Diseases, Inborn | 2 |
| Homozygous Familial Hypercholesterolemia | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Hyperlipoproteinemias | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.